US Health-Care Enforcement Focus Continues To Expand, Officials Say

Reimbursement efforts, individual liability and innovative corporate integrity agreements were among areas of focus at a recent Food and Drug Institute enforcement forum.

More from Regulation

More from Policy & Regulation